Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gastroenterology. 2015 May;148(6):1175-86. doi: 10.1053/j.gastro.2015.01.044. Epub 2015 Feb 3.

Advances in diagnosis and management of celiac disease.

Author information

  • 1Celiac Program, Harvard Medical School and Department of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Electronic address: ckelly2@bidmc.harvard.edu.
  • 2Hospital Gastroenterologia, and Department of Gastroenterology, School of Medicine, Universidad del Salvador, Buenos Aires, Argentina.
  • 3Colorado Center for Celiac Disease, Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • 4Celiac Program, Harvard Medical School and Department of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Abstract

Celiac disease is an autoimmune disorder that is induced by dietary gluten in genetically predisposed individuals. It has a prevalence of approximately 1% in many populations worldwide. New diagnoses have increased substantially, owing to increased awareness, better diagnostic tools, and probable real increases in incidence. The breadth of recognized clinical presentations continues to expand, making the disorder highly relevant to all physicians. Newer diagnostic tools, including serologic tests for antibodies against tissue transglutaminase and deamidated gliadin peptide, greatly facilitate diagnosis. Tests for celiac-permissive HLA-DQ2 and HLA-DQ8 molecules are useful in defined clinical situations. Celiac disease is diagnosed by histopathologic examination of duodenal biopsy specimens. However, according to recent controversial guidelines, a diagnosis can be made without a biopsy in certain circumstances, especially in children. Symptoms, mortality, and risk for malignancy each can be reduced by adherence to a gluten-free diet. This treatment is a challenge, however, because the diet is expensive, socially isolating, and not always effective in controlling symptoms or intestinal damage. Hence, there is increasing interest in developing nondietary therapies.

Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

Autoimmune; Cereal; Diet; Enteritis; Enteropathy; Gluten; Gluten-Free Diet; Lymphoma; Malabsorption; Nutritional Deficiency; Refractory; Serology; Villous Atrophy; Wheat

PMID:
25662623
[PubMed - indexed for MEDLINE]
PMCID:
PMC4409570
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk